Antonio Lalueza to Lopinavir
This is a "connection" page, showing publications Antonio Lalueza has written about Lopinavir.
Connection Strength
0.038
-
Early Lopinavir/ritonavir does not reduce mortality in COVID-19 patients: Results of a large multicenter study. J Infect. 2021 06; 82(6):276-316.
Score: 0.019
-
COVID-19 in solid organ transplant recipients: A single-center case series from Spain. Am J Transplant. 2020 07; 20(7):1849-1858.
Score: 0.018